| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1002/DMRR.3332 |
| P698 | PubMed publication ID | 32343474 |
| P50 | author | Eytan Roitman | Q93339137 |
| Paolo Pozzilli | Q42134282 | ||
| Avivit Cahn | Q59829412 | ||
| Mahmoud Ibrahim | Q88661985 | ||
| Jason Baker | Q93339133 | ||
| P2093 | author name string | Robert H Eckel | |
| Jaakko Tuomilehto | |||
| Guillermo E Umpierrez | |||
| R David Leslie | |||
| Bjørn Richelsen | |||
| Eberhard Standl | |||
| Yoel Toledano | |||
| Peter Gaede | |||
| Amy Hess Fischl | |||
| Dario Tuccinardi | |||
| Nuha Ali El Sayed | |||
| Sandra L Weber | |||
| Silvia Pieralice | |||
| P2860 | cites work | Lifestyle Interventions for Patients With and at Risk for Type 2 Diabetes | Q22305309 |
| Hypoglycemia in type 1 diabetic pregnancy: role of preconception insulin aspart treatment in a randomized study | Q24643284 | ||
| The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 | ||
| Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes | Q30274891 | ||
| Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes | Q30491380 | ||
| Hypoglycemia is the limiting factor in the management of diabetes | Q33683015 | ||
| Hypoglycemia, diabetes, and cardiovascular events | Q33873251 | ||
| Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort | Q33874731 | ||
| Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia | Q33892550 | ||
| Recommendations for management of diabetes during Ramadan: update 2010. | Q34016169 | ||
| Hypoglycemia-associated autonomic failure in diabetes | Q34432976 | ||
| The effect of using the insulin pump bolus calculator compared to standard insulin dosage calculations in patients with type 1 diabetes mellitus - systematic review | Q34553439 | ||
| Maternal hypoglycemia during pregnancy in type 1 diabetes: maternal and fetal consequences | Q34627382 | ||
| Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes | Q34718324 | ||
| Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes | Q34756826 | ||
| Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline | Q34905558 | ||
| Biomarkers related to severe hypoglycaemia and lack of good glycaemic control in ACCORD | Q35561497 | ||
| Insulin therapy and dietary adjustments to normalize glycemia and prevent nocturnal hypoglycemia after evening exercise in type 1 diabetes: a randomized controlled trial | Q35640076 | ||
| Recommendations for management of diabetes during Ramadan: update 2015. | Q35768907 | ||
| Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial | Q35841183 | ||
| Use of an automated bolus calculator reduces fear of hypoglycemia and improves confidence in dosage accuracy in patients with type 1 diabetes mellitus treated with multiple daily insulin injections | Q35874173 | ||
| Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials | Q36330921 | ||
| A clinical trial to maintain glycemic control in youth with type 2 diabetes | Q36340078 | ||
| Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society | Q36782795 | ||
| Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus | Q37435643 | ||
| Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated type 2 diabetes | Q37638840 | ||
| The impact of the Yom Kippur fast on emergency room visits among people with diabetes. | Q38057013 | ||
| The science of hypoglycemia in patients with diabetes | Q38090714 | ||
| Non-islet cell tumor-induced hypoglycemia associated with macronodular pulmonary metastases from poorly differentiated thyroid carcinoma. | Q38108622 | ||
| Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial. | Q47692517 | ||
| A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia | Q48136233 | ||
| Hypoglycaemia manifestations and recurrent events: Lessons from the SAVOR-TIMI 53 outcome study | Q48257790 | ||
| Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype | Q48294114 | ||
| Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial | Q49834635 | ||
| Flash forward: a review of flash glucose monitoring. | Q49884109 | ||
| Renal glucose metabolism in normal physiological conditions and in diabetes | Q50230706 | ||
| Severe hypoglycaemia and late-life cognitive ability in older people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study. | Q50604282 | ||
| Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaS | Q50642265 | ||
| Frequency of symptomatic and asymptomatic hypoglycaemia in Type 1 diabetes: effect of impaired awareness of hypoglycaemia. | Q51158706 | ||
| A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. | Q51527160 | ||
| Evidence that thyroid hormones regulate gluconeogenesis from glycerol in man. | Q51646415 | ||
| Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial. | Q51736633 | ||
| Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. | Q52036530 | ||
| Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus. | Q52053885 | ||
| Accuracy of Continuous Glucose Monitoring before, during, and after Aerobic and Anaerobic Exercise in Patients with Type 1 Diabetes Mellitus. | Q52664471 | ||
| A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes. | Q52712450 | ||
| Diabetes Self-management Education and Support in Type 2 Diabetes. | Q53123708 | ||
| Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. | Q53199148 | ||
| A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with type 1 diabetes in the home or school | Q53824958 | ||
| A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injecti | Q55040580 | ||
| Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. | Q55062500 | ||
| Artificial Intelligence for Diabetes Management and Decision Support: Literature Review. | Q55208803 | ||
| Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial. | Q38381848 | ||
| Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial | Q38381853 | ||
| Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes | Q38400563 | ||
| Minimizing Hypoglycemia in Diabetes | Q38553409 | ||
| Canagliflozin: a sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes mellitus | Q38573559 | ||
| Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment | Q38615808 | ||
| Continuous glucose monitoring detected hypoglycaemia in the Treating to Target in Type 2 Diabetes Trial (4-T). | Q38650939 | ||
| Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial | Q38820633 | ||
| Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes | Q39016044 | ||
| Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association. | Q39031691 | ||
| A Mobile Computerized Decision Support System to Prevent Hypoglycemia in Hospitalized Patients With Type 2 Diabetes Mellitus | Q39218530 | ||
| Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials | Q39323296 | ||
| Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. | Q39376348 | ||
| Health benefits of physical activity: a systematic review of current systematic reviews | Q39435228 | ||
| Long-term outcome of insulin pump therapy: reduction of hypoglycaemia and impact on glycaemic control. | Q40002152 | ||
| Normalization of blood glucose in insulin-dependent diabetic pregnancies and the risks of hypoglycemia: a therapeutic dilemma | Q40613309 | ||
| Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes | Q40693872 | ||
| Hypoglycaemia in pregnancy | Q40850510 | ||
| Improving epinephrine responses in hypoglycemia unawareness with real-time continuous glucose monitoring in adolescents with type 1 diabetes. | Q41280682 | ||
| Clinical Implications of Accuracy Measurements of Continuous Glucose Sensors | Q41776501 | ||
| Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial | Q42691423 | ||
| Continuous glucose monitoring reveals delayed nocturnal hypoglycemia after intermittent high-intensity exercise in nontrained patients with type 1 diabetes | Q42921279 | ||
| Postexercise late-onset hypoglycemia in insulin-dependent diabetic patients | Q43702536 | ||
| Hypoglycemia-associated autonomic failure in advanced type 2 diabetes | Q43901612 | ||
| Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy. | Q43903152 | ||
| Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers | Q43913912 | ||
| Carbohydrate metabolism in hypothyroid myopathy | Q44203478 | ||
| Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients | Q44228686 | ||
| Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia | Q44243542 | ||
| Vital signs, QT prolongation, and newly diagnosed cardiovascular disease during severe hypoglycemia in type 1 and type 2 diabetic patients. | Q44275280 | ||
| Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring | Q44418824 | ||
| Impact of the "Diabetes Interactive Diary" telemedicine system on metabolic control, risk of hypoglycemia, and quality of life: a randomized clinical trial in type 1 diabetes | Q44470572 | ||
| International Consensus on Use of Continuous Glucose Monitoring. | Q45073594 | ||
| Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group | Q45335458 | ||
| Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes | Q45335749 | ||
| Approach to hypoglycemia in infants and children | Q45435076 | ||
| Expert opinion and clinical experience regarding patients with type 1 diabetes mellitus fasting on Yom Kippur. | Q45924914 | ||
| Comparison of continuous blood glucose measurement with conventional documentation of hypoglycemia in patients with Type 2 diabetes on multiple daily insulin injection therapy | Q46885468 | ||
| Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity-onset diabetes of the young type 3. | Q46917131 | ||
| Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control | Q46972109 | ||
| Use of a Smartphone Application to Reduce Hypoglycemia in Type 1 Diabetes: A Pilot Study. | Q47226772 | ||
| Digital Diabetes Management Application Improves Glycemic Outcomes in People With Type 1 and Type 2 Diabetes | Q47250485 | ||
| Cognitive Dysfunction in Older Adults With Diabetes: What a Clinician Needs to Know | Q47569366 | ||
| Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Q56979722 | ||
| Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study | Q57093273 | ||
| A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin | Q57155520 | ||
| Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring | Q57786933 | ||
| Recommendations for management of diabetes and its complications during Hajj (Muslim pilgrimage) | Q58769896 | ||
| Clinical characteristics and outcomes of symptomatic and asymptomatic hypoglycemia in hospitalized patients with diabetes | Q60949468 | ||
| Patient Characteristics Associated With Severe Hypoglycemia in a Type 2 Diabetes Cohort in a Large, Integrated Health Care System From 2006 to 2015 | Q63966611 | ||
| Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies. | Q64965949 | ||
| Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years | Q67932618 | ||
| Embryopathic effects of short-term exposure to hypoglycemia in mouse embryos in vitro | Q68887019 | ||
| Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin | Q70692830 | ||
| Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM | Q72643714 | ||
| Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM | Q72800093 | ||
| United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingd | Q74137575 | ||
| Episodic hyperglycaemia in pregnant women with well-controlled Type 1 diabetes mellitus: a major potential factor underlying macrosomia | Q78223482 | ||
| A 10-s sprint performed prior to moderate-intensity exercise prevents early post-exercise fall in glycaemia in individuals with type 1 diabetes | Q80510727 | ||
| Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes | Q81011993 | ||
| Relationship between hypoglycemic episodes and ventricular arrhythmias in patients with type 2 diabetes and cardiovascular diseases: silent hypoglycemias and silent arrhythmias | Q85857475 | ||
| Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children | Q87276656 | ||
| Liberating A1C goals in older adults may not protect against the risk of hypoglycemia | Q87672602 | ||
| 2017 National Standards for Diabetes Self-Management Education and Support | Q88629803 | ||
| Global status of diabetes prevention and prospects for action: A consensus statement | Q88661989 | ||
| ISPAD Clinical Practice Consensus Guidelines 2018: Assessment and management of hypoglycemia in children and adolescents with diabetes | Q88991778 | ||
| Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial | Q89279033 | ||
| Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report | Q89996332 | ||
| Family Members: The Forgotten Players in the Diabetes Care Team (The TALK-HYPO Study) | Q90009634 | ||
| Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction | Q90176149 | ||
| 6. Glycemic Targets: Standards of Medical Care in Diabetes-2019 | Q90595515 | ||
| 7. Diabetes Technology: Standards of Medical Care in Diabetes-2019 | Q90595518 | ||
| Beyond the brain: do peripheral mechanisms develop impaired awareness of hypoglycemia? | Q90770745 | ||
| A Type 1 diabetes technology pathway: consensus statement for the use of technology in Type 1 diabetes | Q91658263 | ||
| Incretin-based medications (GLP-1 receptor agonists, DPP-4 inhibitors) as a means to avoid hypoglycaemic episodes | Q91676517 | ||
| Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data | Q91706679 | ||
| Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial | Q91706685 | ||
| Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes | Q91787429 | ||
| Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia | Q92073544 | ||
| Incidence and severity of hypoglycaemia in type 2 diabetes by treatment regimen: A UK multisite 12-month prospective observational study | Q92184515 | ||
| Confirming the Bidirectional Nature of the Association Between Severe Hypoglycemic and Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL | Q92286243 | ||
| Use of sensor-integrated pump therapy to reduce hypoglycaemia in people with Type 1 diabetes: a real-world study in the UK | Q92331367 | ||
| Controversies for Glucose Control Targets in Type 2 Diabetes: Exposing the Common Ground | Q92608064 | ||
| Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range | Q92608102 | ||
| Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes | Q92657946 | ||
| Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management | Q92705168 | ||
| Improving pregnancy outcomes in women with diabetes mellitus: modern management | Q92861227 | ||
| Hypoglycemia and Incident Cognitive Dysfunction: A Post Hoc Analysis From the ORIGIN Trial | Q93051670 | ||
| P921 | main subject | hypoglycemia | Q202758 |
| P304 | page(s) | e3332 | |
| P577 | publication date | 2020-04-28 | |
| P1433 | published in | Diabetes - Metabolism: Research and Reviews | Q15750056 |
| P1476 | title | Hypoglycemia and its management in primary care setting |
| Q100938800 | Glucagon for hypoglycaemia treatment in type 1 diabetes |
| Q101116767 | Glucose-lowering pharmacotherapies in Chinese adults with type 2 diabetes and cardiovascular disease or chronic kidney disease. An expert consensus reported by the Chinese Diabetes Society and the Chinese Society of Endocrinology |
Search more.